Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.British Journal of Cancer|September 1, 1990
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))S Marsoni, V Torri, M G Valsecchi, et al.Journal of Medicinal Chemistry|October 1, 1987
Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bondG Bolis, A K Fung, J Greer, et al.Journal of Medicinal Chemistry|February 1, 1988
Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogenH L Sham, G Bolis, H H Stein, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapyM J Piccart, A Floquet, G Scarfone, et al.European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer GroupF H van Wijk, C Lhommé, G Bolis, et al.Journal of Medicinal Chemistry|March 1, 1988
New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 siteJ R Luly, G Bolis, N BaMaung, et al.Cancer|October 1, 1977
Lymphangiography in patients with ovarian epithelial cancer: an evaluation of 289 consecutive casesR Musumeci, A Banfi, G Bolis, et al.British Journal of Cancer|June 13, 2013
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovaryG Mangili, J Ottolina, A Gadducci, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.Pageof 11